The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis

Respiratory Research

Julie Milot¹  Julie Parent¹  Mathieu C Morissette¹ 

[1] Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Canada

关键词: TRAIL;    p53;    oxidative stress;    COPD;    Apoptosis;   

Others  :  796817
DOI  :  10.1186/1465-9921-12-105

 received in 2011-03-24, accepted in 2011-08-08,  发布年份 2011

【 摘 要 】

Background

Alveolar apoptosis is increased in the emphysematous lung. However, mechanisms involved are not fully understood. Recently, we demonstrated that levels of TRAIL receptor 1 and 2, levels of p53, and Bax/Bcl-x_L ratio were elevated in the lung of subjects with emphysema, despite smoking cessation. Thus, we postulate that due to chronic pulmonary oxidative stress, the emphysematous lung would be abnormally sensitive to TRAIL-mediated apoptosis.

Methodology

A549 cells were exposed to rTRAIL, cigarette smoke extract, and/or H₂O₂ prior to caspase-3 activity measurement and annexin V staining assessment. In addition, freshly resected lung samples were obtained from non-emphysematous and emphysematous subjects and exposed ex vivo to rTRAIL for up to 18 hours. Lung samples were harvested and levels of active caspase-3 and caspase-8 were measured from tissue lysates.

Results

Both cigarette smoke extract and H₂O₂ were able to sensitize A549 cells to TRAIL-mediated apoptosis. Moreover, following exposure to rTRAIL, caspase-3 and -8 were activated in lung explants from emphysematous subjects while being decreased in lung explants from non-emphysematous subjects.

Significance of the study

Alveolar sensitivity to TRAIL-mediated apoptosis is strongly increased in the emphysematous lung due to the presence of oxidative stress. This might be a new mechanism leading to increased alveolar apoptosis and persistent alveolar destruction following smoking cessation.

【 授权许可】

   
2011 Morissette et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Mannino DM: COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002, 121:121S-126S.
• [2]Barnes PJ: Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004, 56:515-548.
• [3]Dahlgren C, Karlsson A: Respiratory burst in human neutrophils. J Immunol Methods 1999, 232:3-14.
• [4]Gwinn MR, Vallyathan V: Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev 2006, 9:27-39.
• [5]Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI: 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:490-495.
• [6]Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM: Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007, 9:49-89.
• [7]Martindale JL, Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192:1-15.
• [8]Hainaut P, Wiman KG: 25 Years of p53 Research. Springer 2005.
• [9]Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000, 117:684-694.
• [10]Yokohori N, Aoshiba K, Nagai A: Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004, 125:626-632.
• [11]Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001, 163:737-744.
• [12]Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM: Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 2005, 25:250-258.
• [13]Morissette MC, Vachon-Beaudoin G, Parent J, Chakir J, Milot J: Increased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysema. Am J Respir Crit Care Med 2008, 178:240-247.
• [14]Proulx LI, Pare G, Bissonnette EY: Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke. Cancer Immunol Immunother 2007, 56:831-838.
• [15]Falschlehner C, Emmerich CH, Gerlach B, Walczak H: TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 2007, 39:1462-1475.
• [16]Kim D, Chung J: Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 2002, 35:106-115.
• [17]Graham B, Gibson SB: The two faces of NFkappaB in cell survival responses. Cell Cycle 2005, 4:1342-1345.
• [18]Kwon D, Choi K, Choi C, Benveniste EN: Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res Commun 2008, 372:870-874.
• [19]Perez-Cruz I, Carcamo JM, Golde DW: Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis 2007, 12:225-234.
• [20]Fletcher C, Peto R: The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648.
• [21]Albino AP, Huang X, Jorgensen ED, Gietl D, Traganos F, Darzynkiewicz Z: Induction of DNA double-strand breaks in A549 and normal human pulmonary epithelial cells by cigarette smoke is mediated by free radicals. Int J Oncol 2006, 28:1491-1505.
• [22]Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A: Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 2003, 77:9156-9172.
• [23]Rahman I: Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 2002, 64:935-942.
• [24]Kim KB, Choi YH, Kim IK, Chung CW, Kim BJ, Park YM, Jung YK: Potentiation of Fas- and TRAIL-mediated apoptosis by IFN-gamma in A549 lung epithelial cells: enhancement of caspase-8 expression through IFN-response element. Cytokine 2002, 20:283-288.
• [25]Frese S, Brunner T, Gugger M, Uduehi A, Schmid RA: Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein. J Thorac Cardiovasc Surg 2002, 123:168-174.
• [26]Dandrea T, Hellmold H, Jonsson C, Zhivotovsky B, Hofer T, Warngard L, Cotgreave I: The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic Biol Med 2004, 36:881-896.
• [27]Hsu YL, Cho CY, Kuo PL, Huang YT, Lin CC: Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther 2006, 318:484-494.